179 related articles for article (PubMed ID: 20637357)
1. Protein kinases: From targets to anti-cancer drugs.
Cruzalegui F
Ann Pharm Fr; 2010 Jul; 68(4):254-9. PubMed ID: 20637357
[TBL] [Abstract][Full Text] [Related]
2. Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics.
Kirkland LO; McInnes C
Biochem Pharmacol; 2009 May; 77(10):1561-71. PubMed ID: 19167366
[TBL] [Abstract][Full Text] [Related]
3. Integrated technology platform protein kinases for drug development in oncology.
Sachsenmaier C; Schächtele C
Biotechniques; 2002 Oct; Suppl():101-6. PubMed ID: 12395934
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer with small-molecular-weight kinase inhibitors.
Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G
Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212
[TBL] [Abstract][Full Text] [Related]
7. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
8. SRC as a potential therapeutic target in solid tumor oncology.
Gallick GE
Clin Adv Hematol Oncol; 2004 Jul; 2(7):435-7. PubMed ID: 16163218
[No Abstract] [Full Text] [Related]
9. A functional approach to questions about life, death, and phosphorylation.
Bernards R
Cancer Cell; 2005 Jun; 7(6):503-4. PubMed ID: 15950899
[TBL] [Abstract][Full Text] [Related]
10. [Polyoxometalates. A new class of inorganic CK2 inhibitors].
Prudent R; Hasenknopf B; Cochet C
Med Sci (Paris); 2008 Dec; 24(12):1012-4. PubMed ID: 19116103
[No Abstract] [Full Text] [Related]
11. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease.
Force T; Kuida K; Namchuk M; Parang K; Kyriakis JM
Circulation; 2004 Mar; 109(10):1196-205. PubMed ID: 15023894
[TBL] [Abstract][Full Text] [Related]
12. Promises and drawbacks of targeting cell cycle kinases in cancer.
Pentimalli F; Giordano A
Discov Med; 2009 Dec; 8(43):177-80. PubMed ID: 20040266
[TBL] [Abstract][Full Text] [Related]
13. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
Bogoyevitch MA; Fairlie DP
Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
[TBL] [Abstract][Full Text] [Related]
14. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
Sheinerman FB; Giraud E; Laoui A
J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
[TBL] [Abstract][Full Text] [Related]
15. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
16. Single cell network profiling (SCNP): mapping drug and target interactions.
Covey TM; Putta S; Cesano A
Assay Drug Dev Technol; 2010 Jun; 8(3):321-43. PubMed ID: 20158439
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic targets.
Farley J; Birrer MJ
Cancer Treat Res; 2009; 149():63-84. PubMed ID: 19763431
[No Abstract] [Full Text] [Related]
18. Targeted cancer therapy: promise and reality.
Klein S; Levitzki A
Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
[TBL] [Abstract][Full Text] [Related]
19. Targeting mTOR for cancer treatment.
Rubio-Viqueira B; Hidalgo M
Curr Opin Investig Drugs; 2006 Jun; 7(6):501-12. PubMed ID: 16784020
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer with kinase inhibitors.
Gross S; Rahal R; Stransky N; Lengauer C; Hoeflich KP
J Clin Invest; 2015 May; 125(5):1780-9. PubMed ID: 25932675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]